The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes

Nephrology Dialysis Transplantation

Volumn 28, Issue 2, 2013, Pages 421-429

  Cohen, Gerald ^a   Raupachova, Jana ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

apoptosis; oxidative burst; phagocytosis; polymorphonuclear leucocytes; uraemic toxin

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENYLACETIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

ADULT; ANTIGENS, CD11B; ANTIGENS, CD18; APOPTOSIS; CHEMOTAXIS; FEMALE; HUMANS; INFLAMMATION; MALE; NEUTROPHILS; PHAGOCYTOSIS; PHENYLACETATES; RESPIRATORY BURST; UREMIA;

EID: 84874537377     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs454     Document Type: Article

References (52)

1. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-1533
2. Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997; 62: S79-S82 (Pubitemid 27489411)
3. Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48-S52 (Pubitemid 32144069)
4. Filep JG, El Kebir D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J Cell Biochem 2009; 108: 1039-1046
5. Jankowski J, van der Giet M, Jankowski V et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 2003; 112: 256-264 (Pubitemid 38056361)
6. Davis BA, Shrikhande S, Paralikar VP et al. Phenylacetic acid in CSF and serum in Indian schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 41-47
7. Sandler M, Ruthven CR, Goodwin BL et al. Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values. J Neurol Neurosurg Psychiatry 1982; 45: 366-368 (Pubitemid 12150155)
8. Schmidt S, Westhoff TH, Krauser P et al. The uraemic toxin phenylacetic acid impairs macrophage function. Nephrol Dial Transplant 2008; 23: 3485-3493
9. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943 (Pubitemid 36513344)
10. Vanholder R, Meert N, Schepers E et al. Review on uraemic solutes II-variability in reported concentrations: causes and consequences. Nephrol Dial Transplant 2007; 22: 3115-3121 (Pubitemid 350202539)
11. Meert N, Schepers E, De Smet R et al. Inconsistency of reported uremic toxin concentrations. Artif Organs 2007; 31: 600-611 (Pubitemid 47101111)
12. Duranton F, Cohen G, De Smet R et al. Normal and pathologic concentrations of uremic toxins, a systematic review. J Am Soc Nephrol 2012; 23: 1258-1270
13. Hörl WH, Haag-Weber M, Georgopoulos A et al. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 1990; 87: 6353-6357
14. Cohen G, Haag-Weber M, Mai B et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6: 1592-1599 (Pubitemid 26183542)
15. Cohen G, Rudnicki M, Hörl WH. Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uremic patients. J Am Soc Nephrol 1998; 9: 451-456
16. Cohen G, Rudnicki M, Deicher R et al. Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. Eur J Clin Invest 2003; 33: 669-676 (Pubitemid 36918629)
17. Cohen G, Hörl WH. Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest 2004; 34: 774-781 (Pubitemid 39524303)
18. Cohen G, Raupachova J, Wimmer T et al. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2512-2519
19. Cohen G, Ilic D, Raupachova J et al. Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol 2008; 181: 3761-3768
20. Cohen G, Raupachova J, Ilic D et al. Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients. Nephrol Dial Transplant 2011; 26: 2271-2281
21. Cohen G, Glorieux G, Thornalley P et al. Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro-towards a standardized approach for research on uraemia. Nephrol Dial Transplant 2007; 22: 3381-3390 (Pubitemid 350212473)
22. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004; 2: 820-832 (Pubitemid 39317463)
23. Scholze A, Jankowski V, Henning L et al. Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy. Nephron Clin Pract 2007; 107: c1-c6 (Pubitemid 47360944)
24. Jankowski J, Luftmann H, Tepel M et al. Characterization of dimethylguanosine, phenylethylamine, and phenylacetic acid as inhibitors of Ca2+ ATPase in end-stage renal failure. J Am Soc Nephrol 1998; 9: 1249-1257
25. Falke P, Elneihoum AM, Ohlsson K. Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc Dis 2000; 10: 97-101 (Pubitemid 30107503)
26. Mazzoni MC, Schmid-Schonbein GW. Mechanisms and consequences of cell activation in the microcirculation. Cardiovasc Res 1996; 32: 709-719 (Pubitemid 26332310)
27. Yao Q, Axelsson J, Stenvinkel P et al. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J 2004; 50: lii-lvii
28. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33 (Pubitemid 44000117)
29. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006; 19: 291-296 (Pubitemid 44091703)
30. Mahajan S, Kalra OP, Asit KT et al. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren Fail 2005; 27: 357-360 (Pubitemid 40993681)
31. Sardenberg C, Suassuna P, Andreoli MC et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006; 21: 160-165 (Pubitemid 43057125)
32. Cohen G, Rudnicki M, Walter F et al. Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J Am Soc Nephrol 2001; 12: 1264-1271 (Pubitemid 32472641)
33. Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int 2001; 59: S48-S52 (Pubitemid 32144069)
34. Boudoulas S, Lush RM, McCall NA et al. Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agents. Ther Drug Monit 1996; 18: 714-720 (Pubitemid 26404579)
35. Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 2002; 4: 69-83 (Pubitemid 34260688)
36. Sela S, Shurtz-Swirski R, Cohen-Mazor M et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic lowgrade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-2438 (Pubitemid 41725061)
37. Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif 2002; 20: 70-80 (Pubitemid 34102511)
38. Crockett-Torabi E, Ward PA. The role of leukocytes in tissue injury. Eur J Anaesthesiol 1996; 13: 235-246 (Pubitemid 26158484)
39. Fardon NJ, Wilkinson R, Thomas TH. Rapid fusion of granules with neutrophil cell membranes in hypertensive patients may increase vascular damage. Am J Hypertens 2001; 14: 927-933 (Pubitemid 32862594)
40. Dou L, Brunet P, Dignat-George F et al. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin. Am J Kidney Dis 1998; 31: 67-73 (Pubitemid 28116685)
41. Descamps-Latscha B, Herbelin A, Nguyen AT et al. Immune system dysregulation in uremia. Semin Nephrol 1994; 14: 253-260 (Pubitemid 24148566)
42. Caimi G, Montana M, Carollo C et al. Polymorphonuclear leukocyte integrins in chronic renal failure. Clin Hemorheol Microcirc 2005; 32: 43-49 (Pubitemid 40164159)
43. Heinzelmann M, Mercer-Jones MA, Passmore JC. Neutrophils and renal failure. Am J Kidney Dis 1999; 34: 384-399 (Pubitemid 29362111)
44. Savill J, Fadok V, Henson P et al. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131-136 (Pubitemid 23068298)
45. Jankowski J, Tepel M, Stephan N et al. Characterization of phydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. Kidney Int Suppl 2001; 78: S84-S88 (Pubitemid 32144076)
46. Coxon A, Rieu P, Barkalow FJ et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996; 5: 653-666 (Pubitemid 27062073)
47. Watson RW, Rotstein OD, Nathens AB et al. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol 1997; 158: 945-953 (Pubitemid 127492675)
48. Remijsen Q, Vanden Berghe T, Parthoens E et al. Inhibition of spontaneous neutrophil apoptosis by parabutoporin acts independently of NADPH oxidase inhibition but by lipid raft-dependent stimulation of Akt. J Leukoc Biol 2009; 85: 497-507
49. Knall C, Worthen GS, Johnson GL. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 1997; 94: 3052-3057
50. Frasch SC, Nick JA, Fadok VA et al. p38 mitogen-activated protein kinase-dependent and-independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem 1998; 273: 8389-8397 (Pubitemid 28168900)
51. Arndt PG, Suzuki N, Avdi NJ et al. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways. J Biol Chem 2004; 279: 10883-10891 (Pubitemid 38401578)
52. Wheeler MA, Smith SD, Garcia-Cardena G et al. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99: 110-116 (Pubitemid 27058301)